Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast - 2025

News provided by

Nov 09, 2017, 19:46 ET

LONDON, Nov. 9, 2017 /PRNewswire/ -- DelveInsight's 'Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast-2025' report provides an overview of the Pulmonary Arterial Hypertension (PAH) and market trends of the Pulmonary Arterial Hypertension for the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Rest of Europe (RoE), Japan and Rest of the world (RoW).

Download the full report: https://www.reportbuyer.com/product/5189492

Report covers detailed historical and forecasted epidemiology of Pulmonary Arterial Hypertension covering its sub-type specific prevalence (Idiopathic PAH, Drug/Toxin-induced PAH, Disease associated PAH and Heritable PAH) as well as Gender specific prevalence in 7MM.
The Report also includes the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Pulmonary Arterial Hypertension from 2017 to 2025 segmented by seven major markets as well as RoE and RoW.

Prevalent cases of PAH in the 7MM (US, Germany, Spain, Italy, France, United Kingdom and Japan) were around 70,000 in 2016, out of which females are the ones to be majorly afflicted with this disease, accounting to 70% of the prevalent cases. Among the three major sub-types of PAH i.e., idiopathic PAH, heritable PAH and disease associated PAH, at least 30% prevalent population suffers from idiopathic PAH.

Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Pulmonary Arterial Hypertension (PAH) market.
• Organize sales and marketing efforts by identifying the best opportunities for Pulmonary Arterial Hypertension (PAH) in US, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom), Rest of Europe (RoE), Japan and Rest of the world (RoW).
• The report provides historical as well as forecasted epidemiology of Pulmonary Arterial Hypertension (PAH) in the 7MM covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2025.
• To understand the future market competition in the global Pulmonary Arterial Hypertension (PAH) market and Insightful review of the key market drivers and barriers.
• To understand the regulatory scenario in major markets.
• The Report also covers the detailed global historical and forecasted Pulmonary Arterial Hypertension (PAH) market covering United States, EU5, RoE, Japan and RoW from 2015-2025.

Download the full report: https://www.reportbuyer.com/product/5189492

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com